| # | Drug | Count |
|---|---|---|
| 0 | RITUXIMAB | 8 |
| 1 | CYCLOPHOSPHAMIDE | 7 |
| 2 | CYCLOPHOSPHAMIDE FOR INJECTION | 7 |
| 3 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 7 |
| 4 | DOXORUBICIN | 6 |
| 5 | PREDNISONE | 6 |
| 6 | RIVAROXABAN | 6 |
| 7 | CLOZAPINE | 4 |
| 8 | PANTOPRAZOLE | 4 |
| 9 | PIROXICAM | 4 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | NORGESTREL AND ETHINYL ESTRADIOL | 1 | 0.0011 |
| 1 | PIROXICAM | 4 | 0.0006 |
| 2 | PROPYLTHIOURACIL | 1 | 0.0005 |
| 3 | FLECAINIDE ACETATE | 2 | 0.0004 |
| 4 | INFLIXIMAB-DYYB | 1 | 0.0003 |
| 5 | BASILIXIMAB | 2 | 0.0002 |
| 6 | AMISULPRIDE | 1 | 0.0002 |
| 7 | LOPINAVIR AND RITONAVIR | 2 | 0.0001 |
| 8 | BENDAMUSTINE HCL | 2 | 0.0001 |
| 9 | POLATUZUMAB VEDOTIN | 1 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Dopamine-2 Receptor Antagonist [EPC] | 1 | 0.0001 |
| 1 | Thyroid Hormone Synthesis Inhibitor [EPC] | 1 | 0.0001 |
| 2 | Typical Antipsychotic [EPC] | 2 | 0.0001 |
| 3 | Vasopressin V2 Receptor Antagonist [EPC] | 1 | 0.0001 |
| 4 | Cystic Fibrosis Transmembrane Conductance Regulator Potentiator [EPC] | 1 | 0.0001 |
| 5 | Protease Inhibitor [EPC] | 2 | 0.0000 |
| 6 | Provitamin D2 Compound [EPC] | 1 | 0.0000 |
| 7 | Cytochrome P450 3A Inhibitor [EPC] | 2 | 0.0000 |
| 8 | Sympathomimetic-like Agent [EPC] | 1 | 0.0000 |
| 9 | Alkylating Drug [EPC] | 7 | 0.0000 |